RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
25 nov. 2024 07h00 HE
|
RTI Surgical
ALACHUA, Fla., November 25, 2024 – RTI Surgical ("RTI"), a leading CDMO pushing the boundaries of innovation and tissue engineering to address patient needs in regenerative medicine, today announced...
RTI Surgical Completes Acquisition of Collagen Solutions
01 nov. 2024 08h38 HE
|
RTI Surgical
RTI Surgical Completes Acquisition of Collagen Solutions ALACHUA, Fla., November 1, 2024 – RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
RTI Surgical celebrates expansion of Tutoplast® Tissue Sterilization Process facility
30 oct. 2024 07h17 HE
|
RTI Surgical
Ribbon-cutting ceremony to take place today, in Alachua, Florida ALACHUA, Fla., October 30, 2024; RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...
RTI Surgical Announces Agreement to Acquire Collagen Solutions
07 oct. 2024 07h00 HE
|
RTI Surgical
RTI Surgical Announces Agreement to Acquire Collagen Solutions Further expands RTI’s soft tissue portfolio of xenograft and allograft materials at scaleImproves access to high-growth cardiac,...
RTI Surgical appoints Chad Croasdale as Chief Commercial Officer
10 juil. 2024 07h00 HE
|
RTI Surgical
RTI Surgical appoints Chad Croasdale as Chief Commercial Officer ALACHUA, Fla., July 10, 2024; RTI Surgical ("RTI" or "the Company"), a leading CDMO pushing the boundaries of innovation and tissue...